Talis Biomedical Corp. (TLIS) NASDAQ

$9 - (-)

Market Cap: $16.40M

As of 04/18/24 12:00 AM EDT. Market open.

(TLIS)

Talis Biomedical Corp. (TLIS)
NASDAQ

$9
- (-)

Market Cap: $16.40M

As of 04/18/24 12:00 AM EDT. Market open.

Add to Portfolio

high complexity diagnostics at the point-of-need. bridging the gap between discovery and delivery at slipchip we integrate high-complexity laboratory assays, into an easy to perform, affordable and accessible sample-to-answer format across a wide range of environments. what if physicians could make rapid, individualized optimal treatment decisions? today, patients are often forced to endure days ... read more

high complexity diagnostics at the point-of-need. bridging the gap between discovery and delivery at slipchip we integrate high-complexity laboratory assays, into an easy to perform, affordable and accessible sample-to-answer format across a wide range of environments. what if physicians could make rapid, individualized optimal treatment decisions? today, patients are often forced to endure days of waiting for lab results. as a result, doctors initially treat everyone with a strong cocktail of drugs. this approach is costly and can be harmful to patients.it also leads to serious drug resistance problems. our technology will allow doctors to provide optimal therapies to patients sooner. empowering physicians to make informed treatment decisions quickly. minimizing risks and reducing patient recovery times. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Full Time Employees
157
Address
.
PRICE CHART FOR TALIS BIOMEDICAL CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$9
Days Range
$8.44 - $9
52 week range
$4.35 - $9.32
Volume
1,941
Avg. Volume (30 days)
8,255
Market Cap
$16.40M
Dividend Yield
-
P/E
(0.26)
Shares Outstanding
1,821,986
Open
-
Previous Close
$9
Days Range
$8.44 - $9
52 week range
$4.35 - $9.32
Volume
1,941
Avg. Volume (30 days)
8,255
Market Cap
$16.40M
Dividend Yield
-
P/E
(0.26)
Shares Outstanding
1,821,986
FINANCIAL STATEMENTS FOR TALIS BIOMEDICAL CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TALIS BIOMEDICAL CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BAKER BROS. ADVISORS LPDirectorNov 18, 2021 Buy$4.3650,000218,2507,053,176Nov 19, 2021, 04:09 PM
Ramakrishnan RameshFormer OfficerAug 13, 2021 Option Exercise$1.5052,35578,53366,121Aug 17, 2021, 05:01 PM
Ramakrishnan RameshFormer OfficerAug 13, 2021 Sale$7.6627,502210,66538,619Aug 17, 2021, 05:01 PM
Scott Randal W.DirectorMay 14, 2021 Buy$10.169,00091,4409,000May 18, 2021, 03:19 PM
Scott Randal W.DirectorMay 17, 2021 Buy$10.1111,000111,21020,000May 18, 2021, 03:19 PM
Popovits Kimberly JDirectorFeb 17, 2021 Buy$16.005,30084,800215,090Feb 19, 2021, 06:21 PM
Scott Randal W.DirectorFeb 17, 2021 Buy$16.00312,5005,000,000312,500Feb 19, 2021, 06:18 PM
BAKER BROS. ADVISORS LPDirectorFeb 17, 2021 Buy$16.006,250,000100,000,0007,003,176Feb 19, 2021, 06:17 PM
Ramakrishnan RameshSr. Vice President, R&DFeb 17, 2021 Buy$16.001,00016,0001,000Feb 19, 2021, 06:16 PM
Posard Matthew L.DirectorFeb 17, 2021 Buy$16.0062,5001,000,00062,500Feb 19, 2021, 06:13 PM
Moody John Roger JrChief Financial OfficerFeb 17, 2021 Buy$16.001,70027,2001,700Feb 19, 2021, 06:01 PM
Liu DouglasSr. Vice President, OperationsFeb 17, 2021 Buy$16.004,00064,0004,000Feb 19, 2021, 05:59 PM
Flick Karen E.Chief of Staff, Sr. VP, LegalFeb 17, 2021 Buy$16.002,00032,0002,000Feb 19, 2021, 05:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BAKER BROS. ADVISORS LPDirector11/18/2021218,250
Ramakrishnan RameshFormer Officer08/13/202178,533
Ramakrishnan RameshFormer Officer08/13/2021210,665
Scott Randal W.Director05/14/202191,440
Scott Randal W.Director05/17/2021111,210
Popovits Kimberly JDirector02/17/202184,800
Scott Randal W.Director02/17/20215,000,000
BAKER BROS. ADVISORS LPDirector02/17/2021100,000,000
Ramakrishnan RameshSr. Vice President, R&D02/17/202116,000
Posard Matthew L.Director02/17/20211,000,000
Moody John Roger JrChief Financial Officer02/17/202127,200
Liu DouglasSr. Vice President, Operations02/17/202164,000
Flick Karen E.Chief of Staff, Sr. VP, Legal02/17/202132,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TALIS BIOMEDICAL CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP508,3230.04%No changeOther
GREENLIGHT CAPITAL INC149,0520.05%No changeActivists
GEODE CAPITAL MANAGEMENT, LLC11,2800.00001%No changeOther
BLACKROCK INC.10,4320%111.77%Other
CHANGE IN SHARES OUTSTANDING FOR TALIS BIOMEDICAL CORP
STOCK BUYBACKS FOR TALIS BIOMEDICAL CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.11%
1Q
12/31/2023
06/30/2023
0.21%
2Q
12/31/2023
03/31/2023
1.87%
3Q
12/31/2023
12/31/2022
1.66%
4Q
12/31/2023
09/30/2022
1.10%
5Q
12/31/2023
06/30/2022
1.20%
6Q
12/31/2023
03/31/2022
3.21%
7Q
12/31/2023
12/31/2021
20.58%
8Q
12/31/2023
09/30/2021
5.93%
9Q
12/31/2023
06/30/2021
6.51%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.11%
1Q
06/30/2023
0.21%
2Q
03/31/2023
1.87%
3Q
12/31/2022
1.66%
4Q
09/30/2022
1.10%
5Q
06/30/2022
1.20%
6Q
03/31/2022
3.21%
7Q
12/31/2021
20.58%
8Q
09/30/2021
5.93%
9Q
06/30/2021
6.51%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TALIS BIOMEDICAL CORP
LOADING...